esearchers at a Gaithersburg, MD, pharmaceutical company say they have found that 99 percent of patients with all stages of lung cancer have detectable levels of a particular protein in their blood that healthy individuals do not. The company, Panacea Pharmaceuticals, is reporting encouraging preliminary results for its test for the protein this week at a conference of the American Association for Cancer Research.
Lung cancer survival rates are as high as 80% for stage 0 lung cancer If all lung cancer was detected early then survival rates would be far higher.
Stage 0 Lung Cancer
The lung cancer is localized
Five-Year Survival Rate = 70 – 80%
Stage I Lung Cancer
The lung cancer is confined to the lungs and surrounded by normal tissue.
Five-Year Survival Rate = 50%
Stage II Lung Cancer
The lung cancer has spread to nearby lymph nodes.
Five-Year Survival Rate = 30%
Stage III Lung Cancer
The lung cancer has spread to the chest wall, diaphragm, or other nearby organs or blood vessels.
Five-Year Survival Rate = 5 – 15%
Stage IV Lung Cancer
The lung cancer has spread to more distant sites in the body.
Five-Year Survival Rate = Less than 2%
Genetic tests for prostate cancer are also being developed. Doctors hope that it will make diagnosis of the disease more accurate and reduce the number of biopsies (removal of tissue samples) that are obtained through painful procedures.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.